Diseases
Research conducted by Fudan University has investigated the prevalence of lean metabolic dysfunction-associated fatty liver disease (lean MAFLD) in people living with HIV (PLWH). The study aimed to evaluate the performance of ten diagnostic models in identifying MAFLD in this population. The results showed that lean MAFLD affected 58 (23.
Diseases
Research has identified a significant link between sugar-sweetened beverage (SSB) consumption and the risk of developing metabolic associated fatty liver disease (MAFLD) in patients with type 2 diabetes mellitus (T2DM). A study published in Frontiers in Endocrinology found that individuals with T2DM who consumed SSBs had a higher risk of
Diseases
Researchers from Xuzhou Medical College in Xuzhou, People's Republic of China, have conducted a retrospective study to determine the effects of nonalcoholic fatty liver disease (NAFLD) on chronic hepatitis B virus (HBV) treatment. The study involved 158 patients with chronic HBV who received pegylated interferon (PEG-IFN) therapy in
Diseases
Researchers from Jeju National University have discovered that beta-alanine, a non-essential amino acid, can alleviate non-alcoholic fatty liver disease (NAFLD) in mice. The study, published in Toxicological Research, found that beta-alanine improved NAFLD by regulating hepatic sulfur-amino acid metabolism, reducing oxidative stress, and promoting fat export via very-low-density lipoprotein secretion.
Diseases
Mayo Clinic researchers have identified a key enzyme called valosin-containing protein (VCP) that plays a crucial role in recycling damaged proteins in the liver. When exposed to excessive alcohol, VCP becomes nearly completely removed from the lipid droplet surface, allowing a specific protein called HSD17b13 to accumulate, leading to fatty
Diseases
Research from Mansoura University has revealed a significant association between metabolic syndrome and non-alcoholic fatty liver disease, gonadal dysfunction, and obstructive sleep apnea. The study, published in Diabetology & Metabolic Syndrome, highlights the importance of understanding the pathophysiology of metabolic syndrome and its relationships with these conditions. The findings suggest
Diseases
Research conducted at Yangzhou Wutaishan Hospital of Jiangsu Province, a teaching hospital of Yangzhou University, has shed new light on the relationship between non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM). The study aimed to investigate the characteristics and clinical significance of the uric acid (UA) to
Diseases
Research has shed new light on the complexities of non-alcoholic fatty liver disease (NAFLD) in lean individuals, with significant findings on the correlation between insulin resistance, dyslipidemia, and liver enzyme levels. The study, conducted at a tertiary care hospital, compared lean NAFLD patients with age/sex-matched healthy controls, revealing pronounced
Diseases
Researchers at the University of North Carolina Greensboro have published a new study shedding light on the importance of exercise and diet in preventing non-alcoholic fatty liver disease (NAFLD). The study focuses on the role of cholesterol and triglycerides in the development of NAFLD and highlights the benefits of aerobic
Diseases
Researchers at the University of Health Sciences in Istanbul, Turkey, have made a significant discovery in the field of non-alcoholic fatty liver disease (NAFLD). A study examining the triglyceride (TG)-to-high-density-lipoprotein (HDL) ratio as a potential biomarker for early detection of NAFLD has yielded promising results. The research involved 2,
Fatty liver
Fatty liver disease often develops quietly, silently damaging the liver over time. Palaniappan Manickam, a gastroenterologist, has shed light on the hidden signs of fatty liver disease and the everyday habits that could be harming the liver without people realizing it. According to Dr. Pal, fatty liver starts quietly but
Diseases
A rising concern in the UK is the incidence of fatty liver disease, also known as hepatic steatosis, which affects up to 20% of adults. This condition can lead to inflammation, fibrosis, cirrhosis, and even liver failure or cancer. However, a hepatologist and gastroenterologist, Dr. Saurabh Sethi, has suggested that
